Irene Resch

923 total citations
33 papers, 634 citations indexed

About

Irene Resch is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Irene Resch has authored 33 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Irene Resch's work include Bladder and Urothelial Cancer Treatments (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Urinary and Genital Oncology Studies (7 papers). Irene Resch is often cited by papers focused on Bladder and Urothelial Cancer Treatments (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Urinary and Genital Oncology Studies (7 papers). Irene Resch collaborates with scholars based in Austria, United States and Jordan. Irene Resch's co-authors include Shahrokh F. Shariat, Bernd R. Binder, F Kaindl, Kurt Huber, Kilian M. Gust, Harun Fajković, Danuta Rość, Ernst Schuster, Dietmar H. Glogar and Mesut Remzi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Irene Resch

33 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Resch Austria 13 235 212 178 122 114 33 634
Niels Borgstein United States 12 175 0.7× 54 0.3× 75 0.4× 48 0.4× 88 0.8× 21 594
Ching-Fang Wu Taiwan 8 170 0.7× 172 0.8× 70 0.4× 60 0.5× 27 0.2× 11 814
Olivia Turri Italy 12 61 0.3× 79 0.4× 86 0.5× 87 0.7× 61 0.5× 14 529
Nezih Meydan Türkiye 15 184 0.8× 62 0.3× 323 1.8× 88 0.7× 27 0.2× 44 639
Erik Enquist United States 10 188 0.8× 296 1.4× 29 0.2× 147 1.2× 32 0.3× 13 665
G. Sacchi Italy 17 175 0.7× 344 1.6× 194 1.1× 43 0.4× 49 0.4× 42 848
Wai Keong Wong Singapore 15 136 0.6× 209 1.0× 105 0.6× 63 0.5× 26 0.2× 23 718
Anna Calabrò Italy 18 90 0.4× 135 0.6× 238 1.3× 16 0.1× 249 2.2× 54 1.1k

Countries citing papers authored by Irene Resch

Since Specialization
Citations

This map shows the geographic impact of Irene Resch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Resch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Resch more than expected).

Fields of papers citing papers by Irene Resch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Resch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Resch. The network helps show where Irene Resch may publish in the future.

Co-authorship network of co-authors of Irene Resch

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Resch. A scholar is included among the top collaborators of Irene Resch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Resch. Irene Resch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huebner, Nicolai, Paweł Rajwa, Irene Resch, et al.. (2024). Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET. Urologic Oncology Seminars and Original Investigations. 42(4). 115.e9–115.e16. 3 indexed citations
2.
Pradère, Benjamin, Paweł Rajwa, Gero Kramer, et al.. (2023). Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer. World Journal of Urology. 41(8). 2091–2097. 1 indexed citations
3.
Hassler, Melanie R., Irene Resch, Nicolai Huebner, et al.. (2023). Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of Immunotherapy. European Urology Focus. 10(5). 779–787. 2 indexed citations
4.
Laukhtina, Ekaterina, Reza Sari Motlagh, Keiichiro Mori, et al.. (2021). Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Critical Reviews in Oncology/Hematology. 169. 103570–103570. 9 indexed citations
5.
Gust, Kilian M., Irene Resch, David D‘Andrea, & Shahrokh F. Shariat. (2021). Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature. Translational Andrology and Urology. 10(10). 4051–4061. 6 indexed citations
6.
Quhal, Fahad, Keiichiro Mori, Irene Resch, et al.. (2021). First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. European Urology Oncology. 4(5). 755–765. 98 indexed citations
7.
Resch, Irene, et al.. (2021). Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines. ESMO Open. 6(4). 100122–100122. 4 indexed citations
8.
Laukhtina, Ekaterina, Fahad Quhal, Keiichiro Mori, et al.. (2021). Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 39(11). 764–773. 15 indexed citations
9.
10.
Huebner, Nicolai, Stephan Korn, Irene Resch, et al.. (2020). Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?. European Radiology. 31(6). 3754–3764. 15 indexed citations
11.
Puljak, Livia, Damir Sapunar, Mesut Remzi, et al.. (2019). Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy. World Journal of Urology. 38(8). 1989–1996. 1 indexed citations
12.
Mari, Andrea, David D‘Andrea, Shoji Kimura, et al.. (2018). Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer. Urologia Internationalis. 101(2). 197–200. 12 indexed citations
13.
Resch, Irene, Shahrokh F. Shariat, & Kilian M. Gust. (2018). PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients. memo - Magazine of European Medical Oncology. 11(1). 43–46. 23 indexed citations
14.
Gust, Kilian M., Irene Resch, & David D‘Andrea. (2017). Biomarkers for immunotherapy in urological cancers. Current Opinion in Urology. 28(1). 25–28. 1 indexed citations
15.
Seklehner, Stephan, Paul F. Engelhardt, Mesut Remzi, et al.. (2016). Anxiety and depression analyses of patients undergoing diagnostic cystoscopy. Quality of Life Research. 25(9). 2307–2314. 21 indexed citations
16.
Seklehner, Stephan, Mesut Remzi, Harun Fajković, et al.. (2015). Prospective Multi-institutional Study Analyzing Pain Perception of Flexible and Rigid Cystoscopy in Men. Urology. 85(4). 737–741. 41 indexed citations
17.
Weber, U., Irene Resch, Krista Adelmann, et al.. (2010). Comparison of two new generation pulse oximeters during emergency ambulance transportation. European Journal of Anaesthesiology. 28(2). 92–96. 2 indexed citations
18.
Geiger, Margarethe, et al.. (1992). Possible Identity of Kallikrein Binding Protein with Protein C Inhibitor. Birkhäuser Basel eBooks. 38 ( Pt 1). 182–189. 5 indexed citations
19.
Resch, Irene, et al.. (1990). Association of a significant increase of plasminogen activator inhibitor-1 with the development of coronary restenosis in patients after PTCA. Journal of the American College of Cardiology. 15(2). A209–A209. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Borgstein Breakdown of academic impact, for papers by Ching-Fang Wu Breakdown of academic impact, for papers by Olivia Turri Breakdown of academic impact, for papers by Nezih Meydan Breakdown of academic impact, for papers by Erik Enquist Breakdown of academic impact, for papers by G. Sacchi Breakdown of academic impact, for papers by Wai Keong Wong Breakdown of academic impact, for papers by Anna Calabrò
Rankless by CCL
2026